| Micro-channel |
 |
|
|
|
|
|
| |
| The four categories of medical consumables are expected to reduce the price of some products or record lows |
| |
| Author：中國銘鉉 企劃部 Release Time：2017-9-13 10:51:46 Number Browse：903 |
| |
Medical network on September 13 - the individual import patented drugs after the talks by price "ks" by the state, who planning commission has also launched the high value medical consumables for tomorrow's negotiations, this means that the expensive imported medical consumables standing at the crossroads: over here is the "price for quantity", and the official and folk good will; That is to insist on the high profit niche line unwavering. It is understood that the four categories of products are expected to have a "lower price", and the price of some products is no longer a dream.
After years of calling, the national negotiations on medical supplies are finally coming to fruition. A national health development planning commission issued a "medical consumable price negotiations on the high value to carry out the national enterprise declare work notice, will determine the drug of coronary artery stent system, artificial hip joint prostheses, implantable cardioverter - defibrillator series, series of cardiac resynchronization therapy as a negotiating pilot products, adopt to market in price, about the combination way, concentrated public hospitals (including the army hospital) high value medical consumables market share, to negotiate with production enterprises, form unified purchase price.
High value medical supplies
It is expected to remove the inflated price
The four varieties of the first pilot negotiations are concentrated on imported products, and some are even largely monopolized by importers. In fact, it is not a day for national negotiations to "aim" high medical supplies. In April, the state issued the deepening the reform of medical health system key tasks in 2016, offered to "gradually increase the national drug price negotiation number of drug varieties, reasonable to lower the price of patent medicine and exclusive rights to produce drugs: further promoting high value medical consumables centralized purchasing, online trading, etc." Li binzeng, director of the national health and family planning commission, said in a statement that the state had held talks on some drugs last year, with some even reaching 50 per cent. This year, some high value medical consumables will be piloted in the national price negotiation to remove the inflated water in their prices.
"With the successful experience of the last drug price negotiation, it is estimated that the price cut will not be small. It is possible to cut down half the price. Many of these medical supplies are expensive and have been criticized for a long time." One industry observer told reporters that the health and family planning commission had been "sharpening the knife". Why the cost of medical supplies over the years is too high? As a result of the long-term heavy dependence on imported and "domestic" technology and technical level, the price of products is high.
In the face of national negotiations, enterprises have different calculations. "Some medical equipment manufacturer enthusiasm high, ready 'price for quantity, because even bargain over profit margins exist as well, and once access to health care, sales are expected to usher in a spurt of growth; On the other hand, it is also a kind of proactive 'good show' behavior of foreign companies, which is conducive to its long-term and stable development, so there will be some enterprises willing to lower themselves and negotiate with them. But it does not rule out individual companies sticking to the high-margin niche, the observer said.
In addition, there should be companies on the sidelines, and even likely to change their minds midway through the negotiations.
Some products are expected to be the lowest in the industry
"Whether active or passive depreciate, defend prices don't let go, even the country after negotiations, the four major categories including drug of coronary artery stent, artificial hip prosthesis consumable market prices or to its history, it is very big for patients with positive, because the price difference between different products become smaller, the patient choice will be further expanded, and either out-of-pocket spending less, or at his own expense ratio is lower." The observers believe that country negotiations must be reversed transmission high-value consumables big price cuts, but all the varieties, but not cut estimates of all brands, after all, compared to "lock" in patients with chronic diseases in terms of long-term drug, a lot of material has a "transient" (i.e. a clinical signs or symptoms appear once or several times in a short time, often have obvious incentives), sharply cut price indeed "weakened" will make the enterprise profit, so the manufacturer will according to their own actual situation into perspective.
Guangzhou some 3 armour hospital an orthopaedic professor told our reporter, in fact, in recent years, the use of medical consumables in clinical situation has had the earth-shaking changes, many one-time consumables are more cost-effective took the most "cake", "China" in general "air" has occupied half; But in the high-value medical consumables field, imported products still have the market power of voice and pricing.
Noun explanation
What is national negotiation?
State and production enterprises
Direct determination of purchase price!
What is national negotiation? It is the direct negotiation between the relevant departments of the state and the production enterprises. After the purchase price is determined, public hospitals all over the country are purchasing at the same price. In October 2015, with the approval of the state council, 16 ministries and commissions, including the national health and family planning commission, established coordination mechanisms to organize the first pilot work on drug price negotiations in China. The results of the national drug price negotiation apply to the procurement of public medical institutions, including military systems, and encourage other medical institutions and social pharmacies to purchase directly online.
Because of the country's negotiations is to use all the nation's public medical institutions in together to form a super big market, so for the industry enterprise, which is "about" a major hurdles, is both opportunity and challenge, once be negotiations, state means that the enterprise survival mode, development strategy or disruptive change.
National negotiations
1. Drug coronary stent system
2. Artificial hip prosthesis
3. Implantable arrhythm-based defibrillator series
4. Cardiac resynchronization therapy series
Successful cases
In 2016, the state development planning commission negotiations success of three drugs - tenofovir ester, ek for the treatment and that prices are above 50%, including tenofovir ester the price decreased by 67%, after negotiations monthly drug expenses from 1500 yuan to 490 yuan; The price of gefitinib was reduced by 55%, and the monthly drug cost fell from 15,000 to 7,000 yuan after negotiation. The price cut by ecktini was 54 percent, and the monthly cost of the drug fell from 12,000 yuan to 5,500 yuan per month.
This year, the average price cut of 36 drugs through the national health care negotiations was 44 percent, up from 70 percent. But in these two rounds of negotiations, there are also some drug manufacturers, after the price evaluation, exit negotiation.
|
| |
Previous article：By the end of the 13th five-year plan, the value of medical devices in yantai will be 10 billion yuan
Next article：In the first half of 2017, 15 pharmaceutical companies had sales of 1 billion yuan
|
| |
|
|
